Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

FERVO ENERGY CO (FRVO)

  • SEC News
  • Aug. 12, 2026, 11:05 UTC
  • 0
  • 1 comments

(10% Negative) FERVO ENERGY CO (FRVO) Reports Q3 2026 Financial Results

Comment Full text

BANK OF AMERICA CORP /DE/ (BAC)

  • SEC News
  • Aug. 12, 2026, 11:03 UTC
  • 0
  • 0 comments

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0001918704-26-023514 <b>Size:</b> 1 MB

Comment Full text

HUMACYTE, INC. (HUMA)

  • SEC News
  • Aug. 12, 2026, 11:03 UTC
  • 0
  • 1 comments

(30% Negative) HUMACYTE, INC. (HUMA) Reports Q3 2026 Financial Results

Comment Full text

ACUMEN PHARMACEUTICALS, INC. (ABOS)

  • SEC News
  • Aug. 12, 2026, 11:02 UTC
  • 0
  • 1 comments

(30% Negative) ACUMEN PHARMACEUTICALS, INC. (ABOS) Reports Q3 2026 Financial Results

Comment Full text

TRIMBLE INC. (TRMB)

  • SEC News
  • Aug. 12, 2026, 11:01 UTC
  • 0
  • 1 comments

(100% Positive) TRIMBLE INC. (TRMB) Reports Q3 2026 Financial Results

Comment Full text

CHIRON REAL ESTATE INC. (XRN)

  • SEC News
  • Aug. 12, 2026, 11:00 UTC
  • 0
  • 1 comments

Director Decker Mark Okey Jr 🟢 acquired 8.0K shares of Chiron Real Estate Inc. (XRN) at $35.88 Transaction Date: Aug 10, 2026 | Filing ID: 094437

Comment Full text

SOUND POINT MERIDIAN CAPITAL, INC. (SPME)

  • SEC News
  • Aug. 12, 2026, 11:00 UTC
  • 0
  • 1 comments

(99% Neutral) SOUND POINT MERIDIAN CAPITAL, INC. (SPME) Reports Q3 2026 Financial Results

Comment Full text

CHIRON REAL ESTATE INC. (XRN)

  • SEC News
  • Aug. 12, 2026, 11:00 UTC
  • 0
  • 1 comments

Director Fitzgerald Charles 🟢 acquired 27.6K shares of Chiron Real Estate Inc. (XRN) at $35.94 Transaction Date: Aug 10, 2026 | Filing ID: 094434

Comment Full text

PERFORMANCE FOOD GROUP CO (PFGC)

  • SEC News
  • Aug. 12, 2026, 11:00 UTC
  • 0
  • 1 comments

(80% Positive) PERFORMANCE FOOD GROUP CO (PFGC) Reports Q3 2026 Financial Results

Comment Full text

PROTALIX BIOTHERAPEUTICS, INC. (PLX)

  • SEC News
  • Aug. 12, 2026, 10:59 UTC
  • 0
  • 1 comments

(10% Negative) PROTALIX BIOTHERAPEUTICS, INC. (PLX) Reports Q3 2026 Financial Results

Comment Full text
  • Previous
  • 453
  • 454
  • 455
  • 456
  • 457
  • Next

Search

News categories

  • Technical Exchange News(14277)
  • Event(6229)
  • SEC News(369929)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(227163)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin